Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 mutation and cyclin D1 amplification correlate with cisplatin sensitivity in xenografted human squamous cell carcinomas from head and neck.

Acta oncologica (Stockholm, Sweden) - 1 Jan 2006

Henriksson Eva, Baldetorp Bo, Borg Ake, Kjellen Elisabeth, Akervall Jan, Wennerberg Johan, Wahlberg Peter

Abstract excerpt

To investigate the response of tumour growth to cisplatin treatment, in relation to p53 mutation and cyclin D1 dysregulation on DNA and protein level, biopsies from seven xenografted human squamous cell carcinomas from the head and neck were analysed with immunohistochemistry for p53 expression a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cisplatin
Share to Cyclin D1
Share to Head and Neck Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Laryngeal Neoplasms

Share to Mouth Neoplasms

Share to Neoplasms, Unknown Primary

Share to Statistics as Topic

Share to Xenograft Model Antitumor Assays

Source

Identifiers

PMID: 16644573
DOI: 10.1080/02841860600547380

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-16644573-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 mutation and cyclin D1 amplification correlate with cisplatin sensitivity in xenografted human squamous cell carcinomas from head and neck.PMID 16644573Read ↗

DNA-bound platinum is the major determinant of cisplatin sensitivity in head and neck squamous carcinoma cells.Semantic proximity Read ↗

Genetic and Expression Profiles of Squamous Cell Carcinoma of the Head and Neck Correlate with Cisplatin Sensitivity and Resistance in Cell Lines and PatientsSemantic proximity Read ↗

Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell linesSemantic proximity Read ↗

P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines.Semantic proximity Read ↗

Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck.Semantic proximity Read ↗

KiSS1 mediates platinum sensitivity and metastasis suppression in head and neck squamous cell carcinoma.Semantic proximity Read ↗

The role of p53 in the chemotherapeutic responses to cisplatin, doxorubicin and 5-fluorouracil treatment.Semantic proximity Read ↗

Pharmacodynamics and biodistribution of radiolabeled Platinum-195m (Cisspect) in head and neck squamous cell carcinomaSemantic proximity Read ↗

Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma.Semantic proximity Read ↗

Reduced cisplatin sensitivity of head and neck squamous cell carcinoma cell lines correlates with mutations affecting the COOH-terminal nuclear localization signal of p53.Semantic proximity Read ↗

TP53 gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines.Semantic proximity Read ↗

Influence of vitamin D on cisplatin sensitivity in testicular germ cell cancer-derived cell lines and in a NTera2 xenograft modelSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.